Evonik has posted first-quarter group sales up 7% year-on-year to EUR3.4bn (US$3.8bn), with an improvement in adjusted EBITDA to EUR650m, up 40%.

The outlook for fiscal 2015 has been raised, with sales slightly above the prior year and adjusted EBITDA expected to be at least EUR2.2bn.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

“The positive trend observed in the second half of 2014 has continued,” said Evonik chairman, Klaus Engel.

“Looking at our clear earnings increase, it is pleasing to see three quarters of our 22 business lines were able to improve their earnings year-on-year.

“We should exceed the targets previously forecast for 2015.” 

See Also:

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.